Semaglutide Controversy

Semaglutide, also known as ozempic, has sparked debate due to its potential side effects, including serious health risks like kidney failure and inflammation of the pancreas. Insights reveal that while users may experience weight loss, much of it could be lean mass rather than fat, raising concerns about overall health. Additionally, increased resting heart rates in users suggest potential long-term implications for longevity.